Pharmasintez launched the production of the Sputnik Light vaccine and invested ₽2 billion in it

In mid-December 2021, Pharmasintez launched the production of a vaccine for the COVID-19 Sputnik Light coronavirus, in which the company invested more than 2 billion rubles. The site is located in St. Petersburg.

According to the press service of the company, the production capacity will be about 4 million doses of vaccine per month. After saturation of the domestic market, Pharmasintez plans to export the vaccine to the countries where it is registered, the group added.

Pharmasintez launched the production of the Sputnik Light vaccine and invested ₽2 billion in it

As the president of the group of companies Vikram Punia "Pharmasintez" explained earlier, the process of production of a single-component vaccine from a technical point of view is more convenient and faster and will make it possible to develop large volumes of the drug. He said that at first the company would be able to produce about 1 million doses per month, and by the end of 2021 it was planned to increase the capacity to 1 million doses per week.

For the sake of vaccine production, Pharmasintez-Nord JSC (legal entity of the plant in St. Petersburg) abandoned plans to organize the production of drugs based on monoclonal antibodies. The existing production of cytostatics at the St. Petersburg plant is preserved, Punia noted. The president of Pharmasintez doubts that the immunobiological project will pay off earlier than 2022, considering it more social - the purchase price of the vaccine for the state is about 400 rubles per dose, he says.

The Pharmasintez plant became the ninth in the list of sites engaged in the production of Sputnik Light.

The Pharmasintez group is a large Russian manufacturer of anti-tuberculosis, anti-tumor, antiretroviral drugs and hospital antibiotics. The company's capacities are located in Irkutsk, Bratsk, Ussuriysk, St. Petersburg, Tyumen. By December 2021, Vikram Punia owns 100% of Pharmasintez JSC, the group's management company.^[1]

Notes